Authors' Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19-MedSci.cn - 梅斯（MedSci）

Authors' Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19

Liu, B; Qi, ZG

Qi, ZG (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Pharm, Wuxi 214023, Jiangsu, Peoples R China.

CLINICAL DRUG INVESTIGATION, 2020; 40 (9): 893

科室
- - 订阅+
  - 更多科室
工具
服务